Reuters: Regulatory News: U.S. court lifts block on competitor to AstraZeneca's Nexium

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Manage your social media Best social media tool for image publishing to Facebook and Twitter. Look amazing and delight your followers. Get 40% off when you sign up today. From our sponsors

U.S. court lifts block on competitor to AstraZeneca's Nexium Oct 2nd 2013, 06:27 LONDON | Wed Oct 2, 2013 2:27am EDT LONDON Oct 2 (Reuters) - A U.S. court has lifted a temporary block stopping South Korea's Hanmi Pharmaceutical from launching a close relative of AstraZeneca's Nexium stomach-acid drug in the United States. AstraZeneca said on Wednesday that the U.S. Court of Appeals for the Federal Circuit had removed the temporary injunction on Hanmi's esomeprazole strontium product that had been imposed last month while a legal dispute continues. Britain's second-biggest drugmaker has accused Hanmi of patent infringement by developing the rival drug, which is not chemically identical to Nexium and would not be automatically substitutable for Nexium at pharmacies. Nexium is set to lose U.S. patent protection in 2014.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions